Prospective application of Bayesian monitoring and analysis in an ‘open’ randomized clinical trial

We describe the prospective application of Bayesian monitoring and analysis in an ongoing large multi-centre, randomized trial in which interim results are released to investigators. Substantial variability in prior opinion led us to reject the use of elicited clinical priors for monitoring, in favour of archetypal prior distributions representing reasonable scepticism and enthusiasm. Likelihoods for odds ratios for different covariate values are derived from a logistic regression model, which allows us to incorporate information from prognostic factors without resorting to specialized software. Priors, likelihoods and posterior distributions are regularly reported to both an independent Data Monitoring Committee and the trial investigators.

[1]  Charles Weijer,et al.  Clinical Equipoise and Not the Uncertainty Principle Is the Moral Underpinning of the Randomised Controlled Trial , 2000, BMJ : British Medical Journal.

[2]  R. Lilford.  Formal measurement of clinical uncertainty: prelude to a trial in perinatal medicine , 1994, BMJ.

[3]  P M Fayers,et al.  Tutorial in biostatistics Bayesian data monitoring in clinical trials. , 1997, Statistics in medicine.

[4]  assessment introduction to bayesian methods in health Methods in health service research , 1999 .

[5]  C. Weijer,et al.  For and against: clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial. , 2000, BMJ.

[6]  When do obstetricians recommend delivery for a high-risk preterm growth-retarded fetus? The GRIT Study Group. Growth Restriction Intervention Trial. , 1996, European journal of obstetrics, gynecology, and reproductive biology.

[7]  J B Kadane,et al.  Prime time for Bayes. , 1995, Controlled clinical trials.

[8]  D. Heitjan,et al.  Bayesian interim analysis of phase II cancer clinical trials. , 1997, Statistics in medicine.

[9]  David J. Spiegelhalter,et al.  Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.

[10]  David R. Jones,et al.  An introduction to bayesian methods in health technology assessment , 1999, BMJ.

[11]  David R. Jones,et al.  Bayesian methods in health technology assessment: a review. , 2000, Health technology assessment.

[12]  R J Lilford,et al.  For Debate: The statistical basis of public policy: a paradigm shift is overdue , 1996, BMJ.

[13]  R. Dersimonian,et al.  Meta-analysis in the design and monitoring of clinical trials. , 1996, Statistics in medicine.

[14]  R Simon,et al.  Assessing whether to perform a confirmatory randomized clinical trial. , 1996, Journal of the National Cancer Institute.

[15]  R J Lilford,et al.  Who's afraid Of Thomas Bayes? , 2000, Journal of epidemiology and community health.

[16]  R Peto,et al.  Trials: the next 50 years , 1998, BMJ.